×
Entrez Id: 2
Gene Symbol: A2M
A2M
Liver neoplasms
0.200
Biomarker
RGD
alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers.
15509519 2004
×
Entrez Id: 19
Gene Symbol: ABCA1
ABCA1
Liver neoplasms
0.210
Biomarker
RGD
Hypercholesterolemia in rats with hepatomas: increased oxysterols accelerate efflux but do not inhibit biosynthesis of cholesterol.
16941710 2006
×
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
Liver neoplasms
0.300
Biomarker
RGD
Verapamil and rifampin effect on p-glycoprotein expression in hepatocellular carcinoma.
25625052 2014
×
Entrez Id: 8714
Gene Symbol: ABCC3
ABCC3
Liver neoplasms
0.240
Biomarker
RGD
Differential Expression of Ion Channels and Transporters During Hepatocellular Carcinoma Development.
25842354 2015
×
Entrez Id: 134526
Gene Symbol: ACOT12
ACOT12
Liver neoplasms
0.210
Biomarker
RGD
The biphasic change of cytosolic acetyl-CoA hydrolase in rat liver during 3'-methyl-4-dimethylaminoazobenzene hepatocarcinogenesis.
2566591 1989
×
Entrez Id: 231
Gene Symbol: AKR1B1
AKR1B1
Liver neoplasms
0.200
Biomarker
RGD
Gel-based proteomics of liver cancer progression in rat.
21683810 2011
×
Entrez Id: 208
Gene Symbol: AKT2
AKT2
Liver neoplasms
0.210
Biomarker
RGD
Crosstalk between PTEN/Akt2 and TGFbeta signaling involving EGF receptor down-regulation during the tumor promotion process from the early stage in a rat two-stage hepatocarcinogenesis model.
19309364 2009
×
Entrez Id: 230
Gene Symbol: ALDOC
ALDOC
Liver neoplasms
0.200
Biomarker
RGD
Molecular cloning and expression of rat aldolase C messenger RNA during development and hepatocarcinogenesis.
3830170 1987
×
Entrez Id: 353
Gene Symbol: APRT
APRT
Liver neoplasms
0.240
Biomarker
RGD
The apparent Km values for adenine of liver and hepatoma adenine phosphoribosyltransferase were 0.6 to 0.9 microM, respectively.
6327016 1984
×
Entrez Id: 440
Gene Symbol: ASNS
ASNS
Liver neoplasms
0.500
Biomarker
RGD
L-Asparagine synthetase in serum as a marker for neoplasia.
10081 1976
×
Entrez Id: 718
Gene Symbol: C3
C3
Liver neoplasms
0.210
Biomarker
RGD
Elevated expression of complement C3 protein in chemically induced hepatotumorogenesis in Wistar rats: a correlative proteomics and histopathological study.
23245919 2013
×
Entrez Id: 790
Gene Symbol: CAD
CAD
Liver neoplasms
0.220
Biomarker
RGD
Southern and DNA dot blots indicated amplification of CAD hepatoma 3924A synthase II gene product.
2888462 1987
×
Entrez Id: 790
Gene Symbol: CAD
CAD
Liver neoplasms
0.220
Biomarker
RGD
Increased incidence of CAD gene amplification in tumorigenic rat lines as an indicator of genomic instability of neoplastic cells.
2914957 1989
×
Entrez Id: 23705
Gene Symbol: CADM1
CADM1
Liver neoplasms
0.200
Biomarker
RGD
Expression and DNA methylation patterns of Tslc1 and Dal-1 genes in hepatocellular carcinomas induced by N-nitrosodiethylamine in rats.
17428255 2007
×
Entrez Id: 825
Gene Symbol: CAPN3
CAPN3
Liver neoplasms
0.200
Biomarker
RGD
Calpain-3 gene expression is decreased during experimental cancer cachexia.
10806331 2000
×
Entrez Id: 10498
Gene Symbol: CARM1
CARM1
Liver neoplasms
0.200
Biomarker
RGD
Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis.
23912631 2013
×
Entrez Id: 836
Gene Symbol: CASP3
CASP3
Liver neoplasms
0.260
Therapeutic
RGD
Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.
29133031 2018
×
Entrez Id: 841
Gene Symbol: CASP8
CASP8
Liver neoplasms
0.200
Therapeutic
RGD
Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.
29133031 2018
×
Entrez Id: 842
Gene Symbol: CASP9
CASP9
Liver neoplasms
0.200
Therapeutic
RGD
Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model.
29133031 2018
×
Entrez Id: 898
Gene Symbol: CCNE1
CCNE1
Liver neoplasms
0.220
Biomarker
RGD
Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism.
17196522 2007
×
Entrez Id: 999
Gene Symbol: CDH1
CDH1
Liver neoplasms
0.200
Biomarker
RGD
CpG site hypermethylation of E-cadherin and Connexin26 genes in hepatocellular carcinomas induced by a choline-deficient L-Amino Acid-defined diet in rats.
17295234 2007
×
Entrez Id: 983
Gene Symbol: CDK1
CDK1
Liver neoplasms
0.240
Biomarker
RGD
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
19136513 2009
×
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
RGD
Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma.
11301474 2001
×
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
RGD
Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
16317707 2005
×
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
Liver neoplasms
0.690
Biomarker
RGD
De novo methylation of the p16INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats.
12359353 2002